Evidence map›Paper›PMID 38201152›Full record

ReviewFoods (Basel, Switzerland)2023

Legal Aspects of Microalgae in the European Food Sector.

José Diogo Cruz, Vitor Vasconcelos

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Trends inPlants (Basel, Switzerland) · 2026
    Review
  6. Breeding Chlorophyll-Deficient Mutants ofBioengineering (Basel, Switzerland) · 2026
    Article
  7. Review
  8. Review
  9. Life (Basel, Switzerland) · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Lactic Acid Fermentation ofFoods (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Microalgae biotechnology and its role in sustainable and healthy food design.Frontiers in bioengineering and biotechnology · 2025
    Review
  16. Improved Functionality, Quality, and Shelf Life ofFoods (Basel, Switzerland) · 2024
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

José Diogo CruzFaculty of Sciences, University of Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal.
Vitor VasconcelosFaculty of Sciences, University of Porto, Rua do Campo Alegre, 4169-007 Porto, Portugal.ORCID 0000-0003-3585-2417
Universidade do Porto · PT

Funding

Fundação para a Ciência e Tecnologia UIDB/04423/2020 and UIDP/04423/2020
6 · The paper itself

Abstract

The interest in microalgae as food in Europe is growing due to its remarkable features that can foster a sustainable economy. The lack of tradition on their use among Europeans is changing and a demand for more sustainable products is increasing. The legal framework from the microalgae stakeholders' point of view has been consistently identified as a bottleneck, regardless of its nutritional value and potential to provide added-value metabolites. Microalgae-based products have been mostly consumed as food supplements, which are characterized by some general uncertainty with regards to food security of products sourced from non-European countries. The novel foods regulation is a landmark in Europe's food law defining the conditions in which a new type of food can be commercialized. Currently, a more simplified and centralized version is in place, and around eleven microalgae-based products are on the market; however, more than half are represented by

Indexed as

industrymicroalgaenovel foodsregulation

Identifiers

PMID38201152
PMCPMC10778407
OpenAlexW4390404493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.